Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas.
Fiedler W, DeDosso S, Cresta S, Weidmann J, Tessari A, Salzberg M, Dietrich B, Baumeister H, Goletz S, Gianni L, Sessa C. Fiedler W, et al. Among authors: goletz s. Eur J Cancer. 2016 Aug;63:55-63. doi: 10.1016/j.ejca.2016.05.003. Epub 2016 Jun 7. Eur J Cancer. 2016. PMID: 27285281 Free article. Clinical Trial.
Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas.
Fiedler W, Cresta S, Schulze-Bergkamen H, De Dosso S, Weidmann J, Tessari A, Baumeister H, Danielczyk A, Dietrich B, Goletz S, Zurlo A, Salzberg M, Sessa C, Gianni L. Fiedler W, et al. Among authors: goletz s. ESMO Open. 2018 Feb 1;3(2):e000303. doi: 10.1136/esmoopen-2017-000303. eCollection 2018. ESMO Open. 2018. PMID: 29464112 Free PMC article.
A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options.
Eisner F, Pichler M, Goletz S, Stoeger H, Samonigg H. Eisner F, et al. Among authors: goletz s. J Clin Pathol. 2015 Dec;68(12):1044-6. doi: 10.1136/jclinpath-2015-202996. Epub 2015 Sep 18. J Clin Pathol. 2015. PMID: 26386048 Free PMC article. No abstract available.
Simple separation of DNA in antibody purification.
Christensen PA, Danielczyk A, Stahn R, Goletz S. Christensen PA, et al. Among authors: goletz s. Protein Expr Purif. 2004 Oct;37(2):468-71. doi: 10.1016/j.pep.2004.06.019. Protein Expr Purif. 2004. PMID: 15358372
PankoMab: a potent new generation anti-tumour MUC1 antibody.
Danielczyk A, Stahn R, Faulstich D, Löffler A, Märten A, Karsten U, Goletz S. Danielczyk A, et al. Among authors: goletz s. Cancer Immunol Immunother. 2006 Nov;55(11):1337-47. doi: 10.1007/s00262-006-0135-9. Epub 2006 Feb 17. Cancer Immunol Immunother. 2006. PMID: 16485130 Free PMC article.
103 results